Arcutis Biotherapeutics, Inc. (ARQT): Capital Expenditures
$686.0K
Year ended 2025-12-31
$158.0K
Trailing 12 months to 2026-06-30
+27.2%
3-year compound annual growth
+16.4%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $686.0K | +379.7% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $143.0K | -66.6% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $428.0K | +28.5% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $333.0K | -66.5% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $995.0K | +210.0% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $321.0K | +8.8% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $295.0K | n/a | 2022-02-22, From 2019-01-01 |
| 2018-12-31 | $0 | n/a | 2021-02-16, From 2018-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | $686.0K | +379.7% |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | $48.92M | -49.0% |
| MannKind Corp (MNKD) | 2025-12-31 | $4.57M | -52.9% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $1.49M | +47.6% |
| Innoviva, Inc. (INVA) | 2025-12-31 | $1.13M | +318.9% |
| CorMedix Inc. (CRMD) | 2025-12-31 | $2.26M | n/m |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $8.10M | +43.2% |
| Evolus, Inc. (EOLS) | 2025-12-31 | $3.44M | +133.8% |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $34.0K | -76.1% |
Compare ARQT, SVA, MNKD, ARDX side by side · Screen every company in Pharmaceutical Preparations ↗